Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
Condition: Neovascular (Wet) Age-Related Macular Degeneration Interventions: Drug: aflibercept; Drug: High-Dose aflibercept Sponsors: Regeneron Pharmaceuticals; Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Age-Related Macular Degeneration (AMD) | Research